Catalyst Wire Dossier Catalyst Wire Dossier

Sulfadoxine/pyrimethamine 500/25 mg dispersible tablet

sulfadoxine-pyrimethamine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sulfadoxine/pyrimethamine 500/25 mg dispersible tablet, covering 2024-07-26 to 2024-07-26. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible Tablet [Phase 1]

See pricing